Erin Lavelle

Insider Reports History

Entity
Individual
Location
C/O Alder Biopharmaceuticals, Inc., 11804 North Creek Parkway South, Bothell, WA
Signature
/s/ Sean Smith, Attorney-in-Fact for Erin M. Lavelle
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erin Lavelle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eliem Therapeutics, Inc. COO & CFO Stock Option (Right to Buy) 170K Oct 31, 2022 Direct
Neoleukin Therapeutics, Inc. Director Stock Option (Right to Buy) 25K Jun 8, 2023 Direct

Insider Reports Filed by Erin Lavelle

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NLTX Neoleukin Therapeutics, Inc. Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
ELYM Eliem Therapeutics, Inc. Oct 31, 2022 1 $0 4 Nov 2, 2022 COO & CFO
NLTX Neoleukin Therapeutics, Inc. May 12, 2022 1 $0 4 May 16, 2022 Director
ELYM Eliem Therapeutics, Inc. Jan 27, 2022 1 $0 4 Jan 31, 2022 COO & CFO
ELYM Eliem Therapeutics, Inc. Aug 9, 2021 0 $0 3 Aug 9, 2021 COO & CFO